Two Sigma Investments, LP Madrigal Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $3.43 Million - $4.56 Million	14,852 Added 157.33%	24,292 $5.88 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $551,201 - $2.8 Million	9,440 New	9,440 $2.74 Million
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $5.35 Million - $7.17 Million	-68,235 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$97.2 - $137.59 $10.9 Million - $15.4 Million	-111,980 Reduced 62.14%	68,235 $6.65 Million
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $11.3 Million - $13 Million	104,104 Added 136.78%	180,215 $21.1 Million
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $1.04 Million - $1.27 Million	9,489 Added 14.24%	76,111 $8.46 Million
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $1.07 Million - $1.33 Million	-10,720 Reduced 13.86%	66,622 $7.91 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $3.57 Million - $7.46 Million	59,375 Added 330.47%	77,342 $8.76 Million
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $1.05 Million - $1.47 Million	15,717 Added 698.53%	17,967 $1.2 Million
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $1.14 Million - $1.6 Million	-13,500 Reduced 85.71%	2,250 $205,000
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $1.33 Million - $1.68 Million	15,750 New	15,750 $1.36 Million
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $2.81 Million - $4.07 Million	-13,549 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $1.38 Million - $4.25 Million	13,549 New	13,549 $3.79 Million

296

21.9M

819K

644K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.52B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.